Unstable angina: is it time for a requiem? Circulation. a report from the American Heart Association. Heart disease and stroke statistics-2016 update. Mozaffarian D, Benjamin EJ, Go AS, et al. Heart disease and stroke statistics-2006 update: a report from the American Heart Association Statistics Committee and Stroke Statistics Subcommittee. Development and evolution of electrocardiographic Minnesota Q-QS codes in patients with acute myocardial infarction. Karnegis JN, Matts J, Tuna N, for the POSCH Group. Incidence and predictors of silent myocardial infarction in type 2 diabetes and the effect of fenofibrate: an analysis from the Fenofibrate Intervention and Event Lowering in Diabetes (FIELD) study. The bypass angioplasty revascularization investigation 2 diabetes randomized trial of different treatment strategies in type 2 diabetes mellitus with stable ischemic heart disease: Impact of treatment strategy on cardiac mortality and myocardial infarction. Bypass Angioplasty Revascularization Investigation 2 Diabetes (BARI 2D) Study Group. Chaitman BR, Hardison RM, Adler D, et al. Age- and sex-dependent upper reference limits for the high-sensitivity cardiac troponin T assay. Gore MO, Seliger SL, deFilippi CR, et al. Implications of introducing high-sensitivity cardiac troponin into clinical practice. Melki D, Lugnegård J, Alfredsson J, Lind S, Eggers KM, Lindahl B, Jernberg T. Serial changes in highly sensitive troponin I assay and early diagnosis of myocardial infarction. International Federation of Clinical Chemistry and Laboratory Medicine. An expert consensus document from the Society for Cardiovascular Angiography and Interventions (SCAI). Consideration of a new definition of clinically relevant myocardial infarction after coronary revascularization. Third universal definition of myocardial infarction. Thygesen K, Alpert JS, Jaffe AS, Simoons ML, Chaitman BR, White HD, on behalf of the Joint ESC/ACCF/AHA/WHF Task Force for the Universal Definition of Myocardial Infarction. Universal definition of myocardial infarction. Thygesen K, Alpert JS, White HD, on behalf of the Joint ESC/ACCF/AHA/WHF Task Force for the Redefinition of Myocardial Infarction. Myocardial infarction redefined: a consensus document of the Joint European Society of Cardiology/American College of Cardiology Committee for the Redefinition of Myocardial Infarction. Report of the Joint International Society and Federation of Cardiology/World Health Organization Task Force on Standardization of Clinical Nomenclature. Nomenclature and Criteria for Diagnosis of Ischemic Heart Disease. Disagreements between central clinical events committee and site investigator assessments of myocardial infarction endpoints in an international clinical trial: review of the PURSUIT study. Mahaffey KW, Harrington RA, Akkerhuis M, et al. Do we need to adjudicate major clinical events? Clin Trials. 2014 ACC/AHA key data elements and definitions for cardiovascular endpoint events in clinical trials: a report of the American College of Cardiology/American Heart Association Task Force on Clinical Data Standards (Writing Committee to Develop Cardiovascular Endpoints Data Standards). Guidance for industry: diabetes mellitus-evaluating cardiovascular risk in new antidiabetic therapies to treat type 2 diabetes. Further study is needed to determine whether prospective data collection using these common definitions improves the design, conduct, and interpretability of the results of clinical trials. Use of these definitions at the FDA has enhanced the ability to aggregate data within and across medical product development programs, conduct meta-analyses to evaluate cardiovascular safety, integrate data from multiple trials, and compare effectiveness of drugs and devices. The writing committee recognizes that these definitions may be used in other types of clinical trials and clinical care processes where appropriate. The FDA established the Standardized Data Collection for Cardiovascular Trials Initiative in 2009 to simplify the design and conduct of clinical trials intended to support marketing applications. This publication describes uniform definitions for cardiovascular and stroke outcomes developed by the Standardized Data Collection for Cardiovascular Trials Initiative and the US Food and Drug Administration (FDA). , MDon behalf of the Standardized Data Collection for Cardiovascular Trials Initiative (SCTI) Customer Service and Ordering InformationĢ017 Cardiovascular and Stroke Endpoint Definitions for Clinical Trials.Stroke: Vascular and Interventional Neurology.Journal of the American Heart Association (JAHA).Circ: Cardiovascular Quality & Outcomes.Arteriosclerosis, Thrombosis, and Vascular Biology (ATVB).
0 Comments
Leave a Reply. |
AuthorWrite something about yourself. No need to be fancy, just an overview. ArchivesCategories |